Supreme Court dismisses Pfizer's bid for patent protection of pregabalin

The Supreme Court has dismissed a bid by drug company Pfizer to strengthen the patent protection of pregabalin (Lyrica).
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research